VCG
Vantage Consulting Group Portfolio holdings
AUM
$5.73M
This Quarter Return
-7.33%
1 Year Return
-33.45%
3 Year Return
-18.66%
5 Year Return
–
10 Year Return
–
AUM
$467M
AUM Growth
+$467M
(-19%)
Cap. Flow
-$55M
Cap. Flow
% of AUM
-11.78%
Top 10 Holdings %
Top 10 Hldgs %
86.62%
Holding
221
New
10
Increased
115
Reduced
78
Closed
15
Top Buys
| 1 |
Match Group
MTCH
|
$329K |
| 2 |
Comerica
CMA
|
$229K |
| 3 |
Zions Bancorporation
ZION
|
$222K |
| 4 |
Moderna
MRNA
|
$211K |
| 5 |
Ralph Lauren
RL
|
$203K |
Top Sells
| 1 |
Royalty Pharma
RPRX
|
$52M |
| 2 |
Syntax Stratified US Total Market Hedged ETF
SHUS
|
$3.43M |
| 3 |
Syntax Stratified LargeCap ETF
SSPY
|
$253K |
| 4 |
Alphabet (Google) Class C
GOOG
|
$253K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$247K |
Sector Composition
| 1 | Healthcare | 75.53% |
| 2 | Consumer Staples | 2.42% |
| 3 | Technology | 2.33% |
| 4 | Consumer Discretionary | 2.01% |
| 5 | Energy | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
American Electric Power
AEP
$58.9B
| $237K | 0.05% |
2,917
-92
| -3% | -$7.48K |
|
152
Incyte
INCY
$16.9B
| $236K | 0.05% |
3,434
+676
| +25% | +$46.5K |
|
153
Johnson & Johnson
JNJ
$429B
| $236K | 0.05% |
1,459
+89
| +6% | +$14.4K |
|
154
Tapestry
TPR
$21.4B
| $236K | 0.05% |
6,374
+621
| +11% | +$23K |
|
155
Netflix
NFLX
$516B
| $235K | 0.05% |
385
-81
| -17% | -$49.4K |
|
156
Eli Lilly
LLY
$657B
| $234K | 0.05% |
1,014
+6
| +0.6% | +$1.39K |
|
157
Organon & Co
OGN
$2.43B
| $234K | 0.05% |
7,150
-478
| -6% | -$15.6K |
|
158
Vertex Pharmaceuticals
VRTX
$103B
| $234K | 0.05% |
1,292
+115
| +10% | +$20.8K |
|
|
CTLT
159
DELISTED
CATALENT, INC.
CTLT
| $234K | 0.05% |
1,759
-315
| -15% | -$41.9K |
|
160
Biogen
BIIB
$20.1B
| $230K | 0.05% |
813
+235
| +41% | +$66.5K |
|
161
Entergy
ETR
$39B
| $230K | 0.05% |
2,320
-25
| -1% | -$2.48K |
|
162
Pfizer
PFE
$141B
| $230K | 0.05% |
5,347
-285
| -5% | -$12.3K |
|
|
163
Comerica
CMA
$8.91B
| $229K | 0.05% |
+2,840
| New | +$229K |
|
164
Nike
NKE
$110B
| $229K | 0.05% |
1,578
-361
| -19% | -$52.4K |
|
165
Bristol-Myers Squibb
BMY
$96.5B
| $228K | 0.05% |
3,852
+486
| +14% | +$28.8K |
|
166
Zoetis
ZTS
$67.5B
| $228K | 0.05% |
1,175
-67
| -5% | -$13K |
|
|
SIVB
167
DELISTED
SVB Financial Group
SIVB
| $228K | 0.05% |
352
-7
| -2% | -$4.53K |
|
168
Conagra Brands
CAG
$9.03B
| $227K | 0.05% |
6,714
+867
| +15% | +$29.3K |
|
169
General Mills
GIS
$26.3B
| $227K | 0.05% |
3,799
+310
| +9% | +$18.5K |
|
170
Regeneron Pharmaceuticals
REGN
$60.7B
| $227K | 0.05% |
375
-49
| -12% | -$29.7K |
|
|
PBCT
171
DELISTED
People's United Financial Inc
PBCT
| $226K | 0.05% |
12,913
+1,762
| +16% | +$30.8K |
|
172
Kraft Heinz
KHC
$30.8B
| $225K | 0.05% |
6,106
+1,080
| +21% | +$39.8K |
|
173
Lamb Weston
LW
$7.89B
| $225K | 0.05% |
3,660
+1,055
| +40% | +$64.9K |
|
174
Broadcom
AVGO
$1.4T
| $223K | 0.05% |
460
-21
| -4% | -$10.2K |
|
175
Copart
CPRT
$46.8B
| $222K | 0.05% |
1,598
-222
| -12% | -$30.8K |
|